Skip to content
505(b)2 and Drug Approval Pathways episode artwork

Feb 3, 2025 27 min

505(b)2 and Drug Approval Pathways

from WSPA Ambulatory Care Academy Podcast Hosted by WA State Pharmacy Assoc

Join us for another episode of the Ambulatory Care Academy Podcast where we have an insightful discussion with Darell Connor, AmCA student representative, Doctor of Pharmacy Candidate 2025 from Creighton University and Pharmacy Corporate Project Manager with the American Oncology Network. In this AmCA Podcast, Darell discusses the 505(b)2 drug approval pathways and its impacts. Drug approval has evolved, and how patients may eventually get medications has expanded beyond "FDA drug approval". Listen in as we converse with Darell and learn how the 505(b)2 pathway will impact ambulatory care pharmacy.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

505(b)2 and Drug Approval Pathways

0:00 27:23

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of WSPA Ambulatory Care Academy Podcast?

This episode is 27 minutes long.

When was this WSPA Ambulatory Care Academy Podcast episode published?

This episode was published on February 3, 2025.

Can I download this WSPA Ambulatory Care Academy Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.